(Q46589118)

English

OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion

scientific article published in December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

OCT-guided reinjection of 2.5 mg bevacizumab for treating macular edema due to retinal vein occlusion (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

1 reference

based on heuristic

inferred from title

author name string

A E Höh

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

K B Schaal

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

A Scheuerle

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

F Schütt

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

S Dithmar

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

105

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

12

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

1121-1126

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

https://scigraph.springernature.com/pub.10.1007/s00347-008-1759-2

0 references

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bevacizumab in retinal vein occlusion-results of a prospective case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Bevacizumab for treatment of macular edema secondary to retinal vein occlusion]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Bevacizumab is not toxic to human anterior- and posterior-segment cultured cells]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of in vitro effects of bevacizumab (Avastin) on retinal pigment epithelial, neurosensory retinal, and microvascular endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Bevacizumab for the treatment of macular edema secondary to retinal vein occlusion]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions: IBeVO study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of intravitreal bevacizumab (Avastin)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Testing intravitreal toxicity of bevacizumab (Avastin).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18488232

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00347-008-1759-2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18488232

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46589118&oldid=2165147986"